148 related articles for article (PubMed ID: 37801543)
1. Individual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study.
Hawley K; Lio P; Nguyen T; Qureshi A; Emesiani C; Meckfessel M
J Drugs Dermatol; 2023 Oct; 22(10):SF388641s21-SF388641s26. PubMed ID: 37801543
[TBL] [Abstract][Full Text] [Related]
2. Individual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs.
Hebert AA; Grivet-Seyve M; Anjuwon S; Piccardi N; Lachmann N; Cruz A; Emesiani C
J Drugs Dermatol; 2023 Oct; 22(10):SF388641s5-SF388641s9. PubMed ID: 37801541
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
5. Atopic Dermatitis in Children in the General Population: Baseline Characteristics, Medication Use, and Severity Measures in the Rotterdam Eczema Study.
van Halewijn KF; van der Most F; Bohnen AM; Pasmans SGMA; Bindels PJE; Elshout G
Dermatitis; 2024; 35(1):61-69. PubMed ID: 37015063
[No Abstract] [Full Text] [Related]
6. An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin.
Maghfour J; Rietcheck HR; Rundle CW; Runion TM; Jafri ZA; Dercon S; Lio P; Fernandez J; Fujita M; Dellavalle RP; Yardley H
J Drugs Dermatol; 2020 Dec; 19(12):1204-1208. PubMed ID: 33346512
[TBL] [Abstract][Full Text] [Related]
7. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
[TBL] [Abstract][Full Text] [Related]
8. Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.
Kabashima K; Matsumura T; Hayakawa Y; Kawashima M;
J Dermatolog Treat; 2023 Dec; 34(1):2177096. PubMed ID: 36779675
[TBL] [Abstract][Full Text] [Related]
9. Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
Eichenfield LF; Gower RG; Xu J; Alam MS; Su JC; Myers DE; Sanders P; Vlahos B; Zang C; Lan J; Werth J
Am J Clin Dermatol; 2023 Jul; 24(4):623-635. PubMed ID: 37184828
[TBL] [Abstract][Full Text] [Related]
10. Individual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products.
Hawash A; Nguyen T; Mantilla A; Emesiani C; Meckfessel M
J Drugs Dermatol; 2023 Oct; 22(10):SF388641s10-SF388641s15. PubMed ID: 37801544
[TBL] [Abstract][Full Text] [Related]
11. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study.
Lisante TA; Nuñez C; Zhang P
J Dermatolog Treat; 2017 Nov; 28(7):659-667. PubMed ID: 28366039
[TBL] [Abstract][Full Text] [Related]
13. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
14. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
Zirwas MJ; Barkovic S
J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial.
Ridd MJ; Gaunt DM; Guy RH; Redmond NM; Garfield K; Hollinghurst S; Ball N; Shaw L; Purdy S; Metcalfe C
Br J Dermatol; 2018 Aug; 179(2):362-370. PubMed ID: 29476542
[TBL] [Abstract][Full Text] [Related]
16. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
[TBL] [Abstract][Full Text] [Related]
17. A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children.
Lisante TA; Kizoulis M; Nuñez C; Hartman CL
J Dermatolog Treat; 2023 Dec; 34(1):2241587. PubMed ID: 37592879
[TBL] [Abstract][Full Text] [Related]
18. Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life.
Weber TM; Babcock MJ; Herndon JH; Schoelermann AM; Filbry AW; Scherdin U; Neufang G; Rippke F
J Drugs Dermatol; 2014 May; 13(5):589-95. PubMed ID: 24809884
[TBL] [Abstract][Full Text] [Related]
19. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
[TBL] [Abstract][Full Text] [Related]
20. A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies.
Lisante TA; Nunez C; Zhang P; Mathes BM
J Drugs Dermatol; 2017 Jul; 16(7):671-676. PubMed ID: 28697218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
